1. [1] Menkveld R, Wong WY, Lombard CJ, Wetzels AM, Thomas CM, Merkus HM, et al. Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an effort towards standardization of in-vivo thresholds. Hum Reprod 2001; 16: 1165–1171. [
DOI:10.1093/humrep/16.6.1165]
2. [2] Palermo GD, Neri QV, Cozzubbo T, Rosenwaks Z. Perspectives on the assessment of human sperm chromatin integrity. Fertil Steril 2014; 102: 1508–1517. [
DOI:10.1016/j.fertnstert.2014.10.008]
3. [3] Aitken RJ, De Iuliis GN. Value of DNA integrity assays for fertility evaluation. Soc Reprod Fertil 2007; 65 (Suppl.): 81–92.
4. [4] Simon L, Murphy K, Shamsi MB, Liu L, Emery B, Aston KI, et al. Paternal influence of sperm DNA integrity on early embryonic development. Hum Reprod 2014; 29: 2402–2412. [
DOI:10.1093/humrep/deu228]
5. [5] Oleszczuk K, Giwercman A, Bungum M. Sperm chromatin structure assay in prediction of in vitro fertilization outcome. Andrology 2016; 4: 290–296. [
DOI:10.1111/andr.12153]
6. [6] Bisht S, Dada R. Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front Biosci (Schol Ed) 2017; 9: 420–447. [
DOI:10.2741/s495]
7. [7] Lopes S, Jurisicova A, Sun JG, Casper RF. Reactive oxygen species: potential cause for DNA fragmentation in human spermatozoa. Hum Reprod 1998; 13: 896–900. [
DOI:10.1093/humrep/13.4.896]
8. [8] Aitken RJ, De Iuliis GN, Finnie JM, Hedges A, McLachlan RI. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod 2010; 25: 2415–2426. [
DOI:10.1093/humrep/deq214]
9. [9] Tarin JJ, Brines J, Cano A. Antioxidants may protect against infertility. Hum Reprod 1998; 13: 1415–1416. [
DOI:10.1093/humrep/13.6.1415]
10. [10] Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab 2005;6: 495–501. [
DOI:10.2174/138920005774330594]
11. [11] Imamovic Kumalic S, Pinter B. Review of clinical trials on effects of oral antioxidants on basic semen and other parameters in idiopathic oligoasthenoteratozoospermia. Biomed Res Int 2014; 2014: 426951–426961.
12. [12] Lombardo F, Sansone A, Romanelli F, Paoli D, Gandini L, Lenzi A. The role of antioxidant therapy in the treatment of male infertility: an overview. Asian J Androl 2011; 13: 690–697. [
DOI:10.1038/aja.2010.183]
13. [13] World Health Organization. Examination and processing human semen. 5th Ed. New York, Cambridge University Press; 2010.
14. [14] Boe-Hansen GB, Fedder J, Ersboll AK, Christensen P. The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic. Hum Reprod 2006; 21: 1576–1582. [
DOI:10.1093/humrep/del019]
15. [15] Evenson DP, Larson KL, Jost LK. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. J Androl 2002; 23: 25–43. [
DOI:10.1002/j.1939-4640.2002.tb02599.x]
16. [16] Evgeni E, Charalabopoulos K, Asimakopoulos B. Human sperm DNA fragmentation and its correlation with conventional semen parameters. J Reprod Infertil 2014; 15: 2–14.
17. [17] Aitken RJ, Baker MA. Causes and consequences of apoptosis in spermatozoa; contributions to infertility and impacts on development. Int J Dev Biol 2013; 57: 265–272. [
DOI:10.1387/ijdb.130146ja]
18. [18] Aitken RJ. Reactive oxygen species as mediators of sperm capacitation and pathological damage. Mol Reprod Dev 2017; 84: 1039–1052. [
DOI:10.1002/mrd.22871]
19. [19] Cuasnicu PS, Da Ros VG, Weigel Munoz M, Cohen DJ. Acrosome reaction as a preparation for gamete fusion. Adv Anat Embryol Cell Biol 2016; 220: 159–172. [
DOI:10.1007/978-3-319-30567-7_9]
20. [20] Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2014; 12: CD007411. [
DOI:10.1002/14651858.CD007411.pub3]